Csm Advisors, LLC Biogen Inc. Transaction History

Csm Advisors, LLC

$1.52 Billion
Q1 2024

A detailed history of Csm Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Csm Advisors, LLC holds 28,409 shares of BIIB stock, worth $6.41 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

28,409

Previous 28,139 0.96%

Holding current value

$6.41 Million

Previous $7.28 Million 15.89%

% of portfolio

0.4%

Previous 0.52%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $57,245 - $72,281	270 Added 0.96%	28,409 $6.13 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $19,365 - $23,310	-87 Reduced 0.31%	28,139 $7.28 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $149,447 - $168,675	-590 Reduced 2.05%	28,226 $7.26 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $204,510 - $236,318	-743 Reduced 2.51%	28,816 $8.2 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $461,808 - $526,212	1,800 Added 6.48%	29,559 $8.22 Million

Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $78,256 - $95,083	-310 Reduced 1.1%	27,759 $7.69 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $1.88 Million - $2.59 Million	-9,650 Reduced 25.58%	28,069 $7.5 Million
Q2 2022 Aug 11, 2022	BUY	$187.54 - $223.02 $29,631 - $35,237	158 Added 0.42%	37,719 $7.69 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $561,933 - $708,006	-2,900 Reduced 7.17%	37,561 $7.91 Million
Q4 2021 Feb 09, 2022	SELL	$223.92 - $287.77 $78,372 - $100,719	-350 Reduced 0.86%	40,461 $9.71 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $2,829 - $3,690	-10 Reduced 0.02%	40,811 $11.5 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $106,190 - $170,031	-410 Reduced 0.99%	40,821 $14.1 Million
Q1 2021 May 21, 2021	BUY	$242.95 - $284.63 $10 Million - $11.7 Million	41,231 New	41,231 $11.5 Million

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Csm Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Csm Advisors, LLC with notifications on news.

Account